Bei Hu

1.7k total citations
97 papers, 1.2k citations indexed

About

Bei Hu is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Bei Hu has authored 97 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Oncology and 16 papers in Genetics. Recurrent topics in Bei Hu's work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Bei Hu is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Bei Hu collaborates with scholars based in China, United States and Switzerland. Bei Hu's co-authors include Qingxiong Weng, Shuangyou Liu, Ziyong Sun, Li Ding, E. J. Reed, Xuhui Zhu, Qun Yan, Zhida Sun, Qian Wu and Nilanjan Ghosh and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Bei Hu

86 papers receiving 1.2k citations

Peers

Bei Hu
Timothy Marsh United States
C. Gopinath United Kingdom
Nicki Tiffin South Africa
Bei Hu
Citations per year, relative to Bei Hu Bei Hu (= 1×) peers Xiaowen Zhu

Countries citing papers authored by Bei Hu

Since Specialization
Citations

This map shows the geographic impact of Bei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Hu more than expected).

Fields of papers citing papers by Bei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Hu. The network helps show where Bei Hu may publish in the future.

Co-authorship network of co-authors of Bei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Bei Hu. A scholar is included among the top collaborators of Bei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei Hu. Bei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Bei, Patrick M. Reagan, Laurie H. Sehn, et al.. (2025). Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Advances. 9(10). 2489–2499. 3 indexed citations
2.
Fingrut, Warren, et al.. (2024). The American Society of Hematology Health Equity Compendium: examining health equity across the Blood journals. Blood Advances. 8(17). 4616–4624. 2 indexed citations
3.
Ehsan, Hamid, Tamara K. Moyo, Bei Hu, et al.. (2023). Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T-Cell (CART) Therapy in Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 142(Supplement 1). 7393–7393. 3 indexed citations
4.
Han, Xue, et al.. (2023). Allocholic acid protects against α‐naphthylisothiocyanate‐induced cholestasis in mice by ameliorating disordered bile acid homeostasis. Journal of Applied Toxicology. 44(4). 582–594. 2 indexed citations
5.
Hamadeh, Issam S., Jai N. Patel, Ryan Jacobs, et al.. (2023). Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia. Clinical Cancer Research. 29(23). 4941–4948. 4 indexed citations
6.
Foureau, David, Fei Guo, Nury Steuerwald, et al.. (2023). Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy. Experimental Hematology. 129. 104125–104125. 1 indexed citations
7.
Hu, Bei, et al.. (2022). A missense mutation in lectin domain of thrombomodulin causing functional deficiency. Translational research. 251. 74–83. 4 indexed citations
8.
Zhang, Jin, Bei Hu, Jie Wang, et al.. (2022). One-Step Regeneration of Hairy Roots to Induce High Tanshinone Plants in Salvia miltiorrhiza. Frontiers in Plant Science. 13. 913985–913985. 14 indexed citations
9.
Hu, Bei, Ganjun Yi, Xiaoquan Li, et al.. (2020). Genome-wide analyses of banana fasciclin-like AGP genes and their differential expression under low-temperature stress in chilling sensitive and tolerant cultivars. Plant Cell Reports. 39(6). 693–708. 22 indexed citations
10.
Ding, Cheng, Mengzhou Zhou, Chao Wang, et al.. (2018). Artificial Neural Network–Genetic Algorithm to Optimize Yin Rice Inoculation Fermentation Conditions for Improving Physico-chemical Characteristics. Food Science and Technology Research. 24(4). 729–737. 5 indexed citations
11.
Hu, Bei, Xiaoquan Li, Houbin Chen, et al.. (2018). Comparative Digital Gene Expression Analysis of Tissue-Cultured Plantlets of Highly Resistant and Susceptible Banana Cultivars in Response to Fusarium oxysporum. International Journal of Molecular Sciences. 19(2). 350–350. 24 indexed citations
12.
Hu, Bei, Ryan Jacobs, & Nilanjan Ghosh. (2018). Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma. Current Hematologic Malignancy Reports. 13(6). 543–554. 31 indexed citations
13.
Xu, Chunxiang, et al.. (2017). Pectin methylesterases contribute the pathogenic differences between races 1 and 4 of Fusarium oxysporum f. sp. cubense. Scientific Reports. 7(1). 13140–13140. 25 indexed citations
14.
Wu, Yi‐Long, Qing Zhou, Xiaoqing Liu, et al.. (2017). MA16.06 Phase I/II Study of AC0010, Mutant-Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation. Journal of Thoracic Oncology. 12(1). S437–S438. 10 indexed citations
15.
16.
Hu, Bei. (2013). UPLC-MS/MS determination of rasagiline and 1-aminoindan in human plasma. Yaowu fenxi zazhi. 2 indexed citations
17.
Weng, Qingxiong & Bei Hu. (2009). The Structure of Career Growth and Its Impact on Employees' Turnover Intention. Industrial Engineering and Management. 14(1). 97–104. 35 indexed citations
18.
Hu, Bei. (2008). Relation of Heterogeneity of Knowledge Framework and Occupation Background About Top Management Team and Enterprise Technological Innovation Performance——An Empirical Study Based on Enterprise of Industry Cluster. R and D Management. 1 indexed citations
19.
Geller, Jordan L., et al.. (2008). Increase in Bone Mass After Correction of Vitamin D Insufficiency in Bisphosphonate-Treated Patients. Endocrine Practice. 14(3). 293–297. 28 indexed citations
20.
Liang, T. Jake, Kiyoshi Hasegawa, Santiago J. Muñoz, et al.. (1994). Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation.. Journal of Clinical Investigation. 93(2). 550–555. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026